BeOne Medicines AG (ONC)

BeOne Medicines AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5,098	4,548	2,627	3,183	3,870	4,376
Short-Term Investments	-	-	-	2.6	665.25	2,242
Cash & Short-Term Investments	5,098	4,548	2,627	3,186	4,535	6,618
Cash Growth	84.98%	73.08%	-17.53%	-29.75%	-31.47%	42.29%
Accounts Receivable	1,056	865.08	676.28	358.03	173.17	483.11
Inventory	732.6	608.23	494.99	416.12	282.35	242.63
Other Current Assets	328.98	212.75	192.92	243.39	216.55	270.17
Total Current Assets	7,216	6,234	3,992	4,203	5,207	7,614
Net Property, Plant & Equipment	1,789	1,790	1,718	1,419	955.91	705.04
Other Intangible Assets	60.96	62.7	51.1	57.14	40.62	46.68
Other Long-Term Assets	109.58	102.42	160.49	125.36	175.69	169.93
Total Assets	9,176	8,189	5,921	5,805	6,379	8,536

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	470.3	479.04	405	315.11	294.78	262.4
Accrued Expenses	1,264	1,109	803.71	693.73	467.35	558.06
Short-Term Debt	190.9	57.29	851.53	688.37	328.97	427.57
Current Portion of Long-Term Debt	89.28	56.71	-	-	-	-
Current Portion of Leases	21.95	20.7	17.58	21.95	24.04	21.93
Unearned Revenue	-	-	-	-	213.86	187.41
Other Current Liabilities	82.5	105.97	137.08	90.96	139.52	142.2
Total Current Liabilities	2,119	1,829	2,215	1,810	1,469	1,600
Long-Term Debt	1,699	1,812	166.48	197.62	209.15	202.11
Long-Term Leases	48.2	52.94	44.28	22.25	34.52	43.04
Other Long-Term Liabilities	135.03	133.45	163.03	237.97	283.74	558.25
Total Long-Term Liabilities	1,882	1,999	373.79	457.84	527.41	803.41
Total Liabilities	4,002	3,827	2,589	2,268	1,996	2,403

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.15	0.14	0.14	0.14	0.14	0.13
Additional Paid-in Capital	13,055	12,759	12,088	11,599	11,541	11,191
Accumulated Other Comprehensive Income	-25.37	-78.18	-148.99	-99.45	-77.42	17.95
Retained Earnings	-7,856	-8,320	-8,607	-7,962	-7,080	-5,077
Shareholders' Equity	5,174	4,361	3,332	3,537	4,383	6,133
Total Liabilities & Equity	9,176	8,189	5,921	5,805	6,379	8,536

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2,050	2,000	1,080	930.19	596.68	694.64
Net Cash (Debt)	3,049	2,548	1,548	2,256	3,938	5,923
Net Cash Growth	76.18%	64.63%	-31.39%	-42.73%	-33.51%	44.86%
Net Cash Per Share	6.59	22.46	14.70	21.61	38.19	63.84
Book Value	5,174	4,361	3,332	3,537	4,383	6,133
Book Value Per Share	11.18	38.44	31.65	33.89	42.50	66.09
Tangible Book Value	5,113	4,298	3,281	3,480	4,343	6,086
Tangible Book Value Per Share	11.05	37.89	31.16	33.34	42.11	65.59

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Aug 5, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 6, 2026

Data Sources Report a data error